Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04590820
Title Oral Tazemetostat in Combination With Rituximab in R/R FL
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Swedish Medical Center
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Swedish Cancer Institute Edmonds Campus Edmonds Washington 98026 United States Details
Swedish Cancer Institute Issaquah Campus Issaquah Washington 98029 United States Details
Swedish Medical Center Cancer Institute - First Hill Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from for the field